ATE540975T1 - Verbesserte faktor-viii-polypeptid-titer in zellkulturen - Google Patents

Verbesserte faktor-viii-polypeptid-titer in zellkulturen

Info

Publication number
ATE540975T1
ATE540975T1 AT08749930T AT08749930T ATE540975T1 AT E540975 T1 ATE540975 T1 AT E540975T1 AT 08749930 T AT08749930 T AT 08749930T AT 08749930 T AT08749930 T AT 08749930T AT E540975 T1 ATE540975 T1 AT E540975T1
Authority
AT
Austria
Prior art keywords
factor viii
viii polypeptide
cell cultures
improved factor
polypeptide titer
Prior art date
Application number
AT08749930T
Other languages
English (en)
Inventor
Laust Johnsen
Ida Hilden
Gert Bolt
Thomas Steenstrup
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38519867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE540975(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE540975T1 publication Critical patent/ATE540975T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT08749930T 2007-05-04 2008-04-30 Verbesserte faktor-viii-polypeptid-titer in zellkulturen ATE540975T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107477A EP1988101A1 (de) 2007-05-04 2007-05-04 Verbesserung von Faktor-VIII-Polypeptid-Titern in Zellkulturen
PCT/EP2008/055349 WO2008135501A1 (en) 2007-05-04 2008-04-30 Improvement of factor viii polypeptide titers in cell cultures

Publications (1)

Publication Number Publication Date
ATE540975T1 true ATE540975T1 (de) 2012-01-15

Family

ID=38519867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08749930T ATE540975T1 (de) 2007-05-04 2008-04-30 Verbesserte faktor-viii-polypeptid-titer in zellkulturen

Country Status (14)

Country Link
US (1) US9982033B2 (de)
EP (2) EP1988101A1 (de)
JP (1) JP5506664B2 (de)
KR (1) KR101594805B1 (de)
CN (1) CN101675073B (de)
AT (1) ATE540975T1 (de)
AU (1) AU2008248627B2 (de)
BR (1) BRPI0811177A2 (de)
CA (1) CA2684951A1 (de)
ES (1) ES2379846T3 (de)
MX (1) MX2009011805A (de)
PL (1) PL2144929T3 (de)
RU (1) RU2477318C2 (de)
WO (1) WO2008135501A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
BRPI0716762A2 (pt) 2006-09-13 2013-09-24 Abbott Lab melhorias da cultura celular
TWI610936B (zh) 2008-10-20 2018-01-11 艾伯維有限公司 使用蛋白質ａ親和性層析進行抗體之分離及純化
TW201028433A (en) 2008-10-20 2010-08-01 Abbott Lab Viral inactivation during purification of antibodies
EP2957628A1 (de) 2010-10-05 2015-12-23 Novo Nordisk Health Care AG Verfahren zur proteinherstellung
EP2702077A2 (de) 2011-04-27 2014-03-05 AbbVie Inc. Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen
JP2014533495A (ja) * 2011-11-21 2014-12-15 ノヴォ ノルディスク アー／エス 第ｖｉｉｉ因子の生産のための方法
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
KR101395736B1 (ko) * 2012-07-10 2014-05-16 아주대학교산학협력단 인간 혈액응고인자 ⅷ 도메인 특이적 항체 및 이의 제조방법
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US10844345B2 (en) * 2014-04-16 2020-11-24 Cmc Biologics A/S High density fill and draw fermentation process
NZ729629A (en) 2014-08-04 2021-12-24 Csl Ltd Factor viii formulation
KR20170125941A (ko) 2015-03-06 2017-11-15 체에스엘 베링 리컴비넌트 퍼실리티 아게 개선된 반감기를 갖는 변형된 폰 빌레브란트 인자
KR20220029733A (ko) 2019-07-04 2022-03-08 체에스엘 베링 렝나우 아게 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf)
WO2021094344A1 (en) 2019-11-11 2021-05-20 CSL Behring Lengnau AG Polypeptides for inducing tolerance to factor viii
IL320073A (en) 2022-11-23 2025-06-01 Hoffmann La Roche Method for increasing recombinant protein expression

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5250421A (en) * 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
WO1987004187A1 (en) 1986-01-03 1987-07-16 Genetics Institute, Inc. METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS
DE3769872D1 (de) * 1986-07-11 1991-06-13 Miles Inc Herstellung von rekombinantem protein.
CA1331157C (en) 1987-04-06 1994-08-02 Randal J. Kaufman Method for producing factor viii:c-type proteins
WO1990002175A1 (en) 1988-08-16 1990-03-08 Novo Nordisk A/S A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors
US5679549A (en) 1995-05-04 1997-10-21 Bayer Corporation Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
US5952198A (en) * 1995-05-04 1999-09-14 Bayer Corporation Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition
US5851800A (en) 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6338964B1 (en) 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
CA2436807A1 (en) * 2001-02-05 2002-08-15 Novo Nordisk Health Care Ag Combined use of factor vii polypeptides and factor viii polypeptides
US7351688B2 (en) * 2003-02-05 2008-04-01 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein formulations
US20040229793A1 (en) 2003-02-05 2004-11-18 Balasubramanian Sathyamangalam V. Compositions and methods for less immunogenic protein formulations
EP1707634A1 (de) * 2005-03-29 2006-10-04 Octapharma AG Verfahren zur Isolierung von rekombinant hergestellten Proteinen

Also Published As

Publication number Publication date
KR101594805B1 (ko) 2016-02-17
JP5506664B2 (ja) 2014-05-28
US9982033B2 (en) 2018-05-29
CN101675073B (zh) 2013-12-04
JP2010525829A (ja) 2010-07-29
PL2144929T3 (pl) 2012-06-29
RU2477318C2 (ru) 2013-03-10
AU2008248627B2 (en) 2013-06-06
BRPI0811177A2 (pt) 2014-10-29
ES2379846T3 (es) 2012-05-04
EP2144929A1 (de) 2010-01-20
EP2144929B1 (de) 2012-01-11
US20100120094A1 (en) 2010-05-13
AU2008248627A1 (en) 2008-11-13
KR20100016430A (ko) 2010-02-12
CA2684951A1 (en) 2008-11-13
WO2008135501A1 (en) 2008-11-13
EP1988101A1 (de) 2008-11-05
RU2009143635A (ru) 2011-06-10
MX2009011805A (es) 2009-11-13
CN101675073A (zh) 2010-03-17

Similar Documents

Publication Publication Date Title
ATE540975T1 (de) Verbesserte faktor-viii-polypeptid-titer in zellkulturen
IL252607B (en) Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
CL2011001926A1 (es) Biorreactor para el cultivo de celulas de mamiferos donde dicho biorreactor posee un volumen de al menos 4000 l y al menos un impulsor superior y al menos un impulsor de fondo, donde el impulsor superior es un impulsor de hidroplano; metodo de cultivo; sistema de bioreactor.
NZ630551A (en) Methods and means for the production of ig-like molecules
MY181513A (en) Cell culture compositions and methods for polypeptide production
MX2013014937A (es) Cultivo de celulas de mamifero.
NZ598677A (en) Production of proteins in glutamine-free cell culture media
IN2012DN05207A (de)
EP2438161A4 (de) Verfahren zur herstellung induzierter pluripotenter stammzellen und verfahren zu ihrer kultivierung
EP4148121A3 (de) Zellgesteuerte perfusion in kontinuierlicher kultur
DK2171034T3 (da) Metode til fremstilling af en biopolymer i en kontinuerlig perfusionsgæringsproces
WO2008055190A3 (en) Closed photobioreactor system for production of ethanol
WO2010096588A3 (en) Cell culture media containing combinations of proteins
BRPI0922572A2 (pt) método para cultivar células pluripotentes, cultura de células de mamífero pluripotentes, meio de cultura de célula, célula animal pluripotente isolada, e, método para aumentar a pluripotência de uma célula de mamífero.
IL212387A0 (en) Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products
ECSP11010873A (es) Método de cultivo continuo, recolección y extracción de un microorganismo fotosíntetico
IL192333A0 (en) Photobioreactor, system and method for the cultivation of microalgae
EA200900286A1 (ru) Модификация бактерий для получения этанола
EP2582792A4 (de) Kardiomyozytenmedium mit dialysiertem serum
WO2010020876A3 (en) Cell culture method to form aggregates
EA201491785A1 (ru) Способ ферментации
ATE375385T1 (de) Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
ATE552345T1 (de) Verfahren zur herstellung von fermentationsprodukten
WO2014049382A3 (en) Ethylenediamine fermentative production by a recombinant microorganism
ATE550944T1 (de) Pilzstämme und ein verfahren zur herstellung eines insektizids von diesen stämmen